CON

Profile

Full Name

Concentra Group Holdings Parent, Inc.

Ticker Symbol

CON

Exchange

NYSE

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

May 25, 2010

Indexes

Not included

Website

http://www.concentra.com

Employees

8758

Key Details

Price

$21.25(-0.05%)

Market cap

$2.72B(Mid cap)

Last Dividend

$0.06

TTM Dividend yield

0.29%

Annual revenue

$1.90B(+3.38% YoY)

Annual EPS

$1.46(+2.71% YoY)

PE ratio

17.29

Next earnings date

May 8, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$21.25
CON price is $21.25

30-Day Relative Volume

0.67
CON 30-day relative volume is 0.67

Price Performance

Price Most recent change

-0.05%
CON price was down -0.05% on Apr 25, 2025

Price YTD change

+7.43%
CON price is up +7.43% since January 1st

Price 1-year change

-
CON price 1-year change is unknown

Price 3-year change

-
CON price 3-year change is unknown

Price Range

Price All-time high

$24.80
CON price is currently -14.33% below its historical high of $24.80

Price 3-year low

$18.89
CON price is currently +12.49% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.72B
CON market capitalization is $2.72 billion

Market cap 3-year change

-
CON market capitalization 3-year change is unknown

Market cap All-time high

$3.10B
CON market capitalization is currently -12.04% below its historical high of $3.10 billion

Market cap sector rank

85.38%
CON market capitalization is higher than 85.38% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+1.21%
CON shares outstanding is up +1.21% year-on-year

Shares Outstanding 3-Year Change

-
CON shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.74
CON beta is 0.74

200-day SMA

$21.71
CON price is currently -2.12% below its 200-day simple moving average

50-day SMA

$21.61
CON price is currently -1.65% below its 50-day simple moving average

RSI

52.14
CON 14-day relative strength index is 52.14

Volume

0.67
CON 30-day relative volume is 0.67

ATR

$0.65
CON average true range is $0.65

10-day Historical Volatility

30.59%
CON 10-day historical volatility is 30.59%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.06
CON last dividend was $0.06 per share, with an ex-dividend date of March 18, 2025

Next Dividend

-
CON next dividend has not yet been announced

Dividend per share

Dividend per share

$0.06
CON annual dividend per share is $0.06

Dividend per share Sector Rank

3.41%
CON annual dividend per share is higher than 3.41% of companies in Healthcare sector

Dividend per share 1-Year Change

-
CON annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
CON annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

0.29%
CON annual dividend yield is 0.29%

Dividend yield Sector Rank

4.6%
CON annual dividend yield is higher than 4.6% of companies in Healthcare sector

Other

Payout ratio

926.87%
CON annual payout ratio is 926.87%

Dividends paid

$1.54B
CON annual dividends paid is $1.54 billion

Free cash flow

$210.35M
CON annual free cash flow is $210.35 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.90B
CON annual revenue is $1.90 billion

Revenue Analysts estimate

$2.10B
CON annual revenue is currently -9.70% lower than the consensus analysts' forecast

Revenue 1-year change

+3.38%
CON annual revenue is up +3.38% year-on-year

Revenue Sector rank

84.42%
CON annual revenue is higher than 84.42% of companies in Healthcare sector

EPS

EPS

$1.46
CON annual earnings per share is $1.46

EPS Analysts estimate

$1.33
CON annual earnings per share is currently +9.87% higher than the consensus analysts' forecast

EPS 1-year change

+2.71%
CON annual earnings per share is up +2.71% year-on-year

EPS Sector rank

90.98%
CON annual earnings per share is higher than 90.98% of companies in Healthcare sector

Profit

Gross profit

$527.98M
CON annual gross profit is $527.98 million

Gross margin

27.79%
CON annual gross profit margin is 27.79%

Operating profit

$304.76M
CON annual operating income is $304.76 million

Operating margin

16.04%
CON annual operating profit margin is 16.04%

Net income

$166.54M
CON annual net profit is $166.54 million

Net margin

8.76%
CON annual net profit margin is 8.76%

Expenses

Total expenses

$1.60B
CON annual total expenses is $1.60 billion

Operating expenses

$223.21M
CON annual total operating expenses is $223.21 million

Cost of goods sold

$1.37B
CON annual cost of goods sold is $1.37 billion

Selling, general & administrative expenses

$156.32M
CON annual SGA is $156.32 million

Depreciation and amortization

$67.18M
CON annual depreciation & amortization is $67.18 million

Interest expense

$69.69M
CON annual interest expense is $69.69 million

Income tax

$59.50M
CON annual income tax is $59.50 million

EBIT & EBITDA

EBIT

$301.09M
CON annual earnings before interest & taxes is $301.09 million

EBITDA

$368.26M
CON annual EBITDA is $368.26 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.52B
CON annual total assets is $2.52 billion

Non current assets

$2.08B
CON annual long term assets is $2.08 billion

Current assets

$437.21M
CON annual total current assets is $437.21 million

Cash and cash equivalents

$183.25M
CON annual cash & cash equivalents is $183.25 million

Accounts receivable

$217.72M
CON annual accounts receivable is $217.72 million

Inventory

-
CON annual inventory value is unknown

Liabilities

Total liabilities

$2.22B
CON annual total liabilities is $2.22 billion

Long term liabilities

$1.92B
CON annual total long term liabilities is $1.92 billion

Current liabilities

$307.19M
CON annual total current liabilities is $307.19 million

Accounts payable

$19.75M
CON annual accounts payable is $19.75 million

Debt

Total debt

$1.95B
CON annual total debt is $1.95 billion

Total debt 1-year change

+115.62%
CON annual total debt is up +115.62% year-on-year

Long term debt

$1.87B
CON annual long term debt is $1.87 billion

Short term debt

$85.53M
CON annual short term debt is $85.53 million

Equity & Capital

Shareholders equity

$0.00
CON annual stockholders equity is $0.00

Book value

$275.67M
CON annual book value is $275.67 million

Retained earnings

$13.55M
CON annual retained earnings is $13.55 million

Working capital

$130.02M
CON annual working capital is $130.02 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$274.68M
CON annual cash flow from operations is $274.68 million

Cash from operations 1-year change

+17.23%
CON annual cash flow from operations is up +17.23% year-on-year

Cash from investing

-$71.27M
CON annual cash flow from investing activities is -$71.27 million

Cash from investing 1-year change

+5.37%
CON annual cash flow from investing activities is up +5.37% year-on-year

Cash from financing

-$51.53M
CON annual cash flow from financing activities is -$51.53 million

Cash from financing 1-year change

+68.82%
CON annual cash flow from financing activities is up +68.82% year-on-year

CAPEX

CAPEX

$64.33M
CON annual capital expenditures is $64.33 million

CAPEX 1-year change

-7.23%
CON annual capital expenditures is down -7.23% year-on-year

Free Cash Flow

Free cash flow

$210.35M
CON annual free cash flow is $210.35 million

Free cash flow 1-year change

+27.5%
CON annual free cash flow is up +27.5% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

27.79%
CON annual gross profit margin is 27.79%

Operating margin

16.04%
CON annual operating profit margin is 16.04%

Net margin

8.76%
CON annual net profit margin is 8.76%

ROA & ROE

ROA

6.86%
CON annual return on assets is 6.86%

ROE

22.56%
CON annual return on equity is 22.56%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

17.29
CON price to earnings ratio is 17.29

PE ratio Sector rank

31.37%
CON price to earnings ratio is higher than 31.37% of companies in Healthcare sector

PB Ratio

PB ratio

9.88
CON price to book ratio is 9.88

PB ratio Sector rank

91.28%
CON price to book ratio is higher than 91.28% of companies in Healthcare sector

PS Ratio

PS ratio

1.43
CON price to sales ratio is 1.43

PS ratio Sector rank

33.42%
CON price to sales ratio is higher than 33.42% of companies in Healthcare sector

Enterprise value

Enterprise value

$4.49B
CON enterprise value is $4.49 billion

Enterprise value Sector rank

87.56%
CON enterprise value is higher than 87.56% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.19
CON EV/EBITDA is 12.19

EV/EBITDA Sector rank

85.14%
CON EV/EBITDA is higher than 85.14% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.42
CON annual current ratio is 1.42

Quick ratio

-
CON annual quick ratio value is unknown

Leverage

Debt to equity

-
CON annual debt to equity ratio value is unknown

Interest coverage ratio

4.32
CON annual interest coverage ratio is 4.32

Risk & Stability

Piotroski F-Score

-
CON piotroski f-score value is unknown

Altman Z-Score

1.95
CON altman z-score is 1.95

Analyst ratings

Recent major analysts updates

Mar 19, 25 JP Morgan
Overweight
Mar 12, 25 Wells Fargo
Overweight
Jan 23, 25 RBC Capital
Outperform
Jan 23, 25 B of A Securities
Buy
Dec 16, 24 B of A Securities
Buy
Nov 4, 24 RBC Capital
Outperform
Oct 7, 24 B of A Securities
Neutral
Aug 20, 24 RBC Capital
Outperform
Aug 19, 24 Wells Fargo
Overweight
Aug 19, 24 Truist Securities
Buy

Institutional Ownership

Similar stocks

PTGX logo
Protagonist Therapeutics (PTGX)
XRAY logo
DENTSPLY SIRONA (XRAY)
SGRY logo
Surgery Partners (SGRY)
NVST logo
Envista Holdings (NVST)
PDCO logo
Patterson Companies (PDCO)
PRVA logo
Privia Health (PRVA)
VKTX logo
Viking Therapeutics (VKTX)
CPRX logo
Catalyst Pharmaceuticals (CPRX)
PRCT logo
PROCEPT BioRobotics (PRCT)
  • What is the ticker symbol for Concentra Group Holdings Parent?
  • Does Concentra Group Holdings Parent pay dividends?
  • What sector is Concentra Group Holdings Parent in?
  • What industry is Concentra Group Holdings Parent in?
  • What country is Concentra Group Holdings Parent based in?
  • When did Concentra Group Holdings Parent go public?
  • Is Concentra Group Holdings Parent in the S&P 500?
  • Is Concentra Group Holdings Parent in the NASDAQ 100?
  • Is Concentra Group Holdings Parent in the Dow Jones?
  • When was Concentra Group Holdings Parent's last earnings report?
  • When does Concentra Group Holdings Parent report earnings?
  • Should I buy Concentra Group Holdings Parent stock now?

What is the ticker symbol for Concentra Group Holdings Parent?

The ticker symbol for Concentra Group Holdings Parent is NYSE:CON

Does Concentra Group Holdings Parent pay dividends?

Yes, Concentra Group Holdings Parent pays dividends. The last payment was $0.06, with an ex-dividend date on March 18, 2025

What sector is Concentra Group Holdings Parent in?

Concentra Group Holdings Parent is in the Healthcare sector

What industry is Concentra Group Holdings Parent in?

Concentra Group Holdings Parent is in the Medical Care Facilities industry

What country is Concentra Group Holdings Parent based in?

Concentra Group Holdings Parent is headquartered in United States

When did Concentra Group Holdings Parent go public?

Concentra Group Holdings Parent's initial public offering (IPO) was on May 25, 2010

Is Concentra Group Holdings Parent in the S&P 500?

No, Concentra Group Holdings Parent is not included in the S&P 500 index

Is Concentra Group Holdings Parent in the NASDAQ 100?

No, Concentra Group Holdings Parent is not included in the NASDAQ 100 index

Is Concentra Group Holdings Parent in the Dow Jones?

No, Concentra Group Holdings Parent is not included in the Dow Jones index

When was Concentra Group Holdings Parent's last earnings report?

Concentra Group Holdings Parent's most recent earnings report was on Jan 22, 2025

When does Concentra Group Holdings Parent report earnings?

The next expected earnings date for Concentra Group Holdings Parent is May 8, 2025

Should I buy Concentra Group Holdings Parent stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page